123 related articles for article (PubMed ID: 1818425)
1. Change to Tri-Regol from other oral contraceptives.
Garamvölgyi G
Ther Hung; 1991; 39(3):122-4. PubMed ID: 1818425
[TBL] [Abstract][Full Text] [Related]
2. Observations with a tri-phasic oral contraceptive (Tri-Regol) in everyday clinical practice.
Kovács I; Novák K; Pomázi L; Hammersberg E
Ther Hung; 1992; 40(2):86-9. PubMed ID: 1462283
[TBL] [Abstract][Full Text] [Related]
3. Results of the multilateral study of Tri-Regol tablet.
Seregély G
Ther Hung; 1991; 39(3):136-41. PubMed ID: 1840164
[TBL] [Abstract][Full Text] [Related]
4. Contraception and therapy with Tri Regol tablet.
Adám J
Ther Hung; 1991; 39(2):75-7. PubMed ID: 1948781
[TBL] [Abstract][Full Text] [Related]
5. Use of triphasic Tri-Regol tablet in women of borderline age.
Takács G
Ther Hung; 1991; 39(4):188-91. PubMed ID: 1811332
[TBL] [Abstract][Full Text] [Related]
6. [Tri-Regol and its application in gynecological practice].
Marinov B; Kolarov G
Akush Ginekol (Sofiia); 2000; 39(3):56-7. PubMed ID: 11188001
[TBL] [Abstract][Full Text] [Related]
7. [A clinical study of the triphasic contraceptive Tri-Regol].
Rachev E
Akush Ginekol (Sofiia); 1995; 34(2):64-5. PubMed ID: 8651433
[No Abstract] [Full Text] [Related]
8. Observations with anteovin "step-up" contraceptive tablet in young women.
Takács G; Hámori M
Ther Hung; 1986; 34(3):150-4. PubMed ID: 3441877
[No Abstract] [Full Text] [Related]
9. [Clinical pharmacologic study of Tri-Regol tablets (new oral triphase contraceptives)].
Farkas M; Kovács L; Tasiné Tóth E
Acta Pharm Hung; 1990 May; 60(2-3):85-99. PubMed ID: 2117333
[TBL] [Abstract][Full Text] [Related]
10. Observations with anteovin in family planning advisory unit.
Domány Z
Ther Hung; 1988; 36(1):29-33. PubMed ID: 3388289
[No Abstract] [Full Text] [Related]
11. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
12. The relationship between vascular headaches and low-dose oral contraceptives.
Karsay K
Ther Hung; 1990; 38(4):181-5. PubMed ID: 2094059
[TBL] [Abstract][Full Text] [Related]
13. How rapid is the return of fertility after the use of Tri-Regol oral contraceptive?
Adám J
Ther Hung; 1992; 40(1):16-9. PubMed ID: 1585278
[TBL] [Abstract][Full Text] [Related]
14. Action of hormonal contraceptives on the coagulation system and some of its inhibitors.
Misz M; Beck P
Acta Med Hung; 1986; 43(3):301-10. PubMed ID: 2438639
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic usefulness of anteovin.
Menyhárt K
Ther Hung; 1989; 37(3):168-71. PubMed ID: 2588200
[TBL] [Abstract][Full Text] [Related]
16. [Dermatologic complications of oral hormonal contraception (Gravistat)].
Mikrut W
Wiad Lek; 1986 Nov; 39(21):1462-5. PubMed ID: 3577158
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of Rigevidon used for contraception].
Marianowski L; Grezechocińska B
Ginekol Pol; 1984 Aug; 55(8):631-5. PubMed ID: 6396173
[TBL] [Abstract][Full Text] [Related]
18. [Our experience in using the triphasic contraceptive trisiston for contraception].
Vasilev D; Katsarova M; Dikov I
Akush Ginekol (Sofiia); 1989; 28(3):63-6. PubMed ID: 2802085
[TBL] [Abstract][Full Text] [Related]
19. [Acceptability of hormonal contraceptives with a low steroid content].
Dubnitskaia LV
Akush Ginekol (Mosk); 1988 Aug; (8):47-50. PubMed ID: 3195708
[TBL] [Abstract][Full Text] [Related]
20. Effects of two low-dose oral contraceptives on erythrocyte superoxide dismutase, catalase and glutathione peroxidase activities.
Jendryczko A; Tomala J; Janosz P
Zentralbl Gynakol; 1993; 115(11):469-72. PubMed ID: 8296490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
